These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27118859)

  • 1. Potential pharmacokinetic effect of rifampicin on enrofloxacin in broilers: Roles of P-glycoprotein and BCRP induction by rifampicin.
    Guo M; Dai X; Hu D; Zhang Y; Sun Y; Ren W; Wang L
    Poult Sci; 2016 Sep; 95(9):2129-35. PubMed ID: 27118859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E. coli infection modulates the pharmacokinetics of oral enrofloxacin by targeting P-glycoprotein in small intestine and CYP450 3A in liver and kidney of broilers.
    Guo M; Sun Y; Zhang Y; Bughio S; Dai X; Ren W; Wang L
    PLoS One; 2014; 9(1):e87781. PubMed ID: 24498193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of piperine and quercetin alone or in combination with marbofloxacin on CYP3A37 and MDR1 mRNA expression levels in broiler chickens.
    Patel HB; Patel UD; Mathapati BS; Modi CM
    Res Vet Sci; 2019 Oct; 126():178-183. PubMed ID: 31539794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of anemoside B4 on pharmacokinetics of florfenicol and mRNA expression of CXR, MDR1, CYP3A37 and UGT1E in broilers.
    Li S; Li X; Yang R; Wang B; Li J; Cao L; Xiao S; Huang W
    J Vet Med Sci; 2019 Dec; 81(12):1804-1809. PubMed ID: 31611492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chicken xenobiotic receptor upregulates the BCRP/ABCG2 transporter.
    Xu Z; Li M; Lu W; Wang L; Zhang Y
    Poult Sci; 2023 Jan; 102(1):102278. PubMed ID: 36402040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related P-glycoprotein expression in the intestine and affecting the pharmacokinetics of orally administered enrofloxacin in broilers.
    Guo M; Bughio S; Sun Y; Zhang Y; Dong L; Dai X; Wang L
    PLoS One; 2013; 8(9):e74150. PubMed ID: 24066110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory Effect of Berberine on Broiler P-glycoprotein Expression and Function: In Situ and In Vitro Studies.
    Zhang Y; Guo L; Huang J; Sun Y; He F; Zloh M; Wang L
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of quercetin in animal feed: effects on the P-gp expression and pharmacokinetics of orally administrated enrofloxacin in chicken.
    Bhutto ZA; He F; Zloh M; Yang J; Huang J; Guo T; Wang L
    Sci Rep; 2018 Mar; 8(1):4400. PubMed ID: 29535328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using the lentiviral vector system to stably express chicken P-gp and BCRP in MDCK cells for screening the substrates and studying the interplay of both transporters.
    Zhang Y; Huang J; Liu Y; Guo T; Wang L
    Arch Toxicol; 2018 Jun; 92(6):2027-2042. PubMed ID: 29725709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allicin affects the pharmacokinetics of sulfadiazine and florfenicol by downregulating the expression of jejunum P-gp and BCRP in broilers.
    Wang X; Wang Y; Fang C; Gong Q; Huang J; Zhang Y; Wang L
    Poult Sci; 2022 Jul; 101(7):101947. PubMed ID: 35688033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin pharmacokinetics in healthy Chinese subjects and its relations with CYP2C9, CYP3A5, ABCB1, ABCG2 and SLCO1B1 polymorphisms.
    Zhou Q; Ruan ZR; Jiang B; Yuan H; Zeng S
    Pharmazie; 2013 Feb; 68(2):124-8. PubMed ID: 23469684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of berberine on the pharmacokinetics of florfenicol and levels of cytochrome P450 3A37, multidrug resistance 1, and chicken xenobiotic-sensing orphan nuclear receptor mRNA expression in broilers.
    Li S; Wang B; Zhang M; Yuan D; Li J; Li X; Liang G
    Vet Med Sci; 2022 Mar; 8(2):619-625. PubMed ID: 34766459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of variations in the amounts of P-glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the human small intestine on PBPK models for predicting intestinal first pass.
    Bruyère A; Declèves X; Bouzom F; Ball K; Marques C; Treton X; Pocard M; Valleur P; Bouhnik Y; Panis Y; Scherrmann JM; Mouly S
    Mol Pharm; 2010 Oct; 7(5):1596-607. PubMed ID: 20604570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-glycoprotein Limits Ribociclib Brain Exposure and CYP3A4 Restricts Its Oral Bioavailability.
    Martínez-Chávez A; van Hoppe S; Rosing H; Lebre MC; Tibben M; Beijnen JH; Schinkel AH
    Mol Pharm; 2019 Sep; 16(9):3842-3852. PubMed ID: 31329454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragali radix and its main bioactive compounds activate the Nrf2-mediated signaling pathway to induce P-glycoprotein and breast cancer resistance protein.
    Lou Y; Guo Z; Zhu Y; Zhang G; Wang Y; Qi X; Lu L; Liu Z; Wu J
    J Ethnopharmacol; 2019 Jan; 228():82-91. PubMed ID: 30243825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivermectin induces chicken BCRP/ABCG2 expression and function: Involvement of CXR signaling pathway and mRNA stabilization.
    Xu Z; Li M; Lu W; Li L; Zhang Y; Wang L
    J Vet Pharmacol Ther; 2022 Nov; 45(6):558-569. PubMed ID: 35924758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids modulate multidrug resistance transporters in the first trimester human placenta.
    Lye P; Bloise E; Nadeem L; Gibb W; Lye SJ; Matthews SG
    J Cell Mol Med; 2018 Jul; 22(7):3652-3660. PubMed ID: 29691980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of drug efflux and uptake transporters ABCB1 (P-gp), ABCG2 (BCRP) and OATP1A/1B and of CYP3A4 in the pharmacokinetics of the CDK inhibitor milciclib.
    Martínez-Chávez A; Broeders J; Lebre MC; Tibben MT; Rosing H; Beijnen JH; Schinkel AH
    Eur J Pharm Sci; 2021 Apr; 159():105740. PubMed ID: 33524505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCB1 and ABCG2 limit brain penetration and, together with CYP3A4, total plasma exposure of abemaciclib and its active metabolites.
    Martínez-Chávez A; Loos NHC; Lebre MC; Tibben MM; Rosing H; Beijnen JH; Schinkel AH
    Pharmacol Res; 2022 Apr; 178():105954. PubMed ID: 34700018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneously predict pharmacokinetic interaction of rifampicin with oral versus intravenous substrates of cytochrome P450 3A/P‑glycoprotein to healthy human using a semi-physiologically based pharmacokinetic model involving both enzyme and transporter turnover.
    Qian CQ; Zhao KJ; Chen Y; Liu L; Liu XD
    Eur J Pharm Sci; 2019 Jun; 134():194-204. PubMed ID: 31047967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.